CHICAGO, Nov 21 (Reuters) – Controversial heart disease
prevention guidelines that abandoned specific targets for
reducing “bad” LDL cholesterol are under fresh assault after a
major study highlighted the benefits of taking LDL to very low
Guidelines issued last year by the American Heart
Association and the American College of Cardiology asked doctors
to assess individual patients’ risk for heart disease over 10
years based on a complex calculation of risks posed by
lifestyle, family history and other health conditions. Those
deemed at sufficient risk would be prescribed
CHICAGO (Reuters) – Gene sequencing equipment maker Illumina has teamed up with the U.S. government and academic researchers at the Broad Institute in Boston to train scientists in West Africa to improve tracking of how the Ebola virus is mutating in hopes of fighting it more effectively.
The public-private partnership, announced on Wednesday, is designed to extend research on how the Ebola virus is mutating in real time as it spreads among populations in West Africa. Scientists need the information to develop new diagnostics, drugs and vaccines to fight the outbreak.
CHICAGO (Reuters) – Rare mutations in a single gene may help lower cholesterol and reduce the risk of a heart attack by half, U.S. researchers said on Wednesday in a study that could have implications for Merck and Co’s closely watched heart drug Zetia.
The study involved individuals with mutations in a gene called NPC1L1, the gene targeted by Zetia, a cholesterol fighter known generically as ezetimibe.
CHICAGO, Nov 7 (Reuters) – Etienne Simon-Loriere of the
Pasteur Institut in Paris has his fingers crossed. He is heading
to West Africa on Sunday to inspect blood samples gathered from
Ebola patients in Guinea in hopes of tracing the path of the
virus in the country where the current outbreak began.
Such samples are scarce and precious. So far, only a few
scientists have them, and many more say they need them in order
to do critical research on the virus.
CHICAGO (Reuters) – Scientists across the United States say they cannot obtain samples of Ebola, complicating efforts to understand how the virus is mutating and develop new drugs, vaccines and diagnostics.
The problems reflect growing caution by regulators and transport companies about handling Ebola as well as the limited resources of West African countries which are struggling to help thousands of infected citizens.
CHICAGO (Reuters) – Scientists have been puzzling for years over why some people survive Ebola while many others perish. A new study provides strong evidence that individual genetic differences play a major role in whether people die from the disease.
Researchers at the University of Washington in Seattle reported their findings on Thursday in the journal Science.
CHICAGO (Reuters) – An analysis of the first Ebola cases in Sierra Leone helps draw a clearer picture of why some people survive the disease, while others do not, including their age and the pace at which the virus replicates within their body.
The study published Wednesday is based on data gathered from 106 patients diagnosed with Ebola at the Kenema Government Hospital in Sierra Leone from May 25 to July 18. Some of the data on this group was incinerated because of fears that the nurses’ station where the records were kept became contaminated.
NEW YORK/CHICAGO (Reuters) – As a New York City doctor tests positive for Ebola after volunteering in West Africa, health officials face the challenge of deciding how wide a net to cast for his possible contacts in the largest, most crowded city in the United States.
Dr. Craig Spencer, an emergency doctor who was working with Doctors Without Borders in Ebola-stricken Guinea earlier this month, returned to the city last Friday.
CHICAGO/NEW YORK (Reuters) – The Ebola crisis is forcing the American healthcare system to consider the previously unthinkable: withholding some medical interventions because they are too dangerous to doctors and nurses and unlikely to help a patient.
U.S. hospitals have over the years come under criticism for undertaking measures that prolong dying rather than improve patients’ quality of life.
CHICAGO, Oct 22 (Reuters) – U.S. health officials are
setting up a network of about 20 go-to hospitals to handle the
care of an Ebola patient rather than rely on any facility to
treat the virus, according to comments from a senior
The United States is moving “fairly rapidly” to a “sort of a
tiered and regionalized approach to Ebola care,” Dr. Nicole
Lurie, the assistant secretary for preparedness and response at
the Department of Health and Human Services, said on a call with
hospital administrators on Monday, according to an official